3 - Pediatric TB
3 - Pediatric TB
3 - Pediatric TB
Abdulwahhab S
1
Learning objectives
At the end of this lesson, learners will be able to:
Define tuberculosis
Describe the pathophysiology of Tuberculosis
Describe clinical manifestations of tuberculosis
Describe diagnostic methods of tuberculosis in
children
Explain the management of tuberculosis in children
2
Tuberculosis (TB)
Definition
Tuberculosis (TB) is an infectious disease caused by
Mycobacterium tuberculosis, a rod-shaped bacillus
called “acid-fast” due to its staining characteristics
in laboratory.
Occasionally the disease can also be caused by
Mycobacterium bovis and Mycobacterium
africanum.
3
Epidemiology
Tb is a major public health problem throughout the
world.
The World Health Organization estimates that 8 to
10 million people develop tuberculosis in the world
every year and 3 to 5 million die from tuberculosis.
Approximately 1.3 million cases of tuberculosis and
400,000 tuberculous-related deaths occur annually
among children younger than 15 years.
4
Cont’d
The global burden of TB is increasing due to:
HIV epidemics
Poverty
Crowding
5
Etiology
Mycobacterium Tuberculous complex:
M.TB
M.Bovis
M.Africanum
M.Microti
M.Canetti
6
Cont’d
All belong to the order Actinomycetales and family Mycobacteriaceae
M.TB
Non-spore forming
Non-motile
Obligate aerobe
Slow-growing
Cell wall with high lipid content which gives “acid-fast” staining
properties (resistance to decolorization with acid alcohol)
7
Transmission &
Pathogenesis
Incubation period from infection to
development of +ve tuberculin test is 2-
6wks
Transmission is person to person (usually by
air borne mucus droplet nuclei)
8
Cont’d
Risk of transmission is dependent on :
Index case;
Smear positive TB
Extensive upper lobe infiltrate & cavity
Copious production of sputum
Severe & forceful cough
Not treated
Environment:
Poor ventilation
Overcrowding
Intimacy
9
Cont’d
Young children (<7yrs) rarely infect others b/c:
Sparse bacilli
Cough is often absent or lacks the tussive force
to suspend infectious particles of correct size
M.bovis may penetrate the GI mucosa or invade
the lymphatic tissue of oropharynx when large
numbers are ingested.
10
Cont’d
The pathologic events in the initial tuberculous
infection depend on the balance between:
Mycobacterial antigen load
Cell-mediated immunity(enhance IC killing)
Tissue hypersensitivity(promotes
extracellular killing)
11
Cont’d
When Ag load is small & tissue hypersensitivity is
high
granuloma formation (from organization of
lymphocytes, macrophages and fibroblasts)
When both (Ag & sensitivity) are high:
12
Cont’d
When degree of tissue sensitivity is low
(infants, low immunity)
Diffuse reaction
Infection is not well contained
13
Cont’d
Factors that predispose to serious disease:
Young age
Genetic factors
14
Pathogenesis
The 1o complex of TB includes local infection at the portal of
entry & regional LNs
Lung is portal of entry in more than 98% of cases
Bacilli multiply initially within alveoli & alveolar ducts
Most are killed, some survive within nonactivated macrophages
Macrophages carry the bacilli to regional LNs by lymphatic
vessels
If lung is portal of entry, hilar LNs are often involved but
paratracheal LNs may be involved(upper lobe)
15
Cont’d
Tissue reaction in the lung parenchyma & LNs intensifies over the
next 2-12wks
The parenchymal lesion of 1o complex often heals completely
by fibrosis or calcification.
Occasionally may continue to enlarge & result in focal
pneumonitis & pleuritis
If caseation is intense, center of the lesion liquefies & empties
into the bronchus leaving a residual cavity
The infection of regional LNs develop some fibrosis &
encapsulation, but healing is usually incomplete.
Viable M.TB can persist for decades within parenchymal or LN
foci
16
Cont’d
If hilar & Para tracheal LNs enlarge (as part of host
inflammatory reaction), they may encroach on a
regional LN bronchus partial obstruction
bronchus distal hyperinflation
complete obstruction results in atelectasis
Inflamed caseous nodes can attach to the
bronchial wall & erode through it, causing
endobronchial TB or a fistula tract.
During the development of 1o complex, bacilli
are carried to most tissues of the body through
the blood & lymphatic vessels; common seeding
is in the organs of Reticuloendothelial System.
17
Cont’d
Bacterial replication occurs in organs with conditions that favor
their growth:
Lung apices
Brain
Kidneys
Bones
Disseminated TB occurs if:
Circulating number of bacilli is large and
Host immune response is inadequate
18
Cont’d
The time b/n initial infection & clinically apparent disease is variable:
Disseminated & meningeal TB are early manifestations (2-6 month
after infection)
TB LAP & endobronchial TB (3-9month)
Bones & joints take several years
Renal TB takes decades(10yrs) after infection
19
Clinical manifestations
Pulmonary Tuberculosis:
21
TB Lymphadenitis:
Is the commonest form.
Regardless of HIV status, the lymph nodes most
commonly involved are the cervical nodes.
Generalized lymphadenopathy can occur in children with
HIV infection,
Reduced immunity and
In symptomatic HIV infected children who are given
BCG vaccination.
22
Tuberculosis of the Spine or
Joints:
Is the second commonest form of childhood EPTB, and
may occur within the first few years following primary
infection.
Usually affects weight bearing bones or joints.
The most common sites are spine, hip, knee and
ankle.
Early diagnosis of TB of the spine is essential to prevent
the disastrous consequence leading to paralysis.
23
Miliary Tuberculosis:
Presents with constitutional features rather than
respiratory symptoms.
Early symptoms are vague and lack specificity.
Lassitude, anorexia, failure to thrive and prolonged
unexplained fever are common.
24
CNS TB:
Is the result of hematogenous spread of the bacilli to the CNS.
obstructive hydrocephalus.
26
Perinatal TB
Can be congenital
C/ms;
Similar to sepsis & other neonatal problems.
May manifest early but common time is 2-3wks of age (RD, poor feeding, fever,
HSM, FTT, abdominal distension)
Dx and Mx of Perinatal TB
27
Cont’d
At 3months, PPD (purified protein derivative) skin
test.
if +ve, continue for 6-9 months
If non-reactive, give BCG and Dic. INH
Isolation of the newborn:
Seriously sick mother
Previous Rx for TB
Suspected drug resistant TB
28
Diagnosis of TB in Children
Key Features Suggestive of TB
Chronic symptoms suggestive of TB
Physical signs highly suggestive of TB
X-ray suggestive of TB
A positive tuberculin skin test
29
Recommended Approach to
Diagnose TB in Children
Clinical Assessment
Typical Symptoms
Cough, especially persistent and non-
improving
Weight loss or failure to gain weight
Fever and/or night sweats
Fatigue, reduced playfulness, inactivity
30
History of Contact
Contact such as with a source case of Pulmonary TB
living in the same household or a chronic cougher.
A source case with sputum smear-positive PTB is
more likely to infect contacts than cases with sputum
smear-negative PTB; however, cases with EPTB are
not infectious though.
Children usually develop TB within 2 years after
exposure and most (90%) within the first year.
31
Clinical Examination
Special emphasis on weight measurement (look
for weight loss or poor weight gain), fever, signs
of respiratory distress and chest finding.
Children can also present with acute severe
pneumonia (especially in infants and HIV-infected
children) as well as asymmetrical and persistent
wheeze.
32
Tuberculin Skin
Test(Mantoux test)
Id, 0.1ml, 5TU of PPD/purified protein derivative/, volar
surface of arms
T-cells sensitized by prior infection are recruited to the
skin; release lymphokines that induce indurations
through local vasodilatation, edema, fibrin deposition
and recruitment of other inflammatory cells to the area.
Amount of induration is measured 48-72hrs after
administration.
33
Cont’d
TST is useful to support a diagnosis of TB in children
with suggestive clinical features who are sputum
smear-negative or who cannot produce sputum.
A positive TST indicates infection:
Positive in any child if ≥ 10 mm, irrespective of
BCG immunization; and also
Positive if ≥ 5 mm in HIV-infected or severely
malnourished child.
34
Cont’d
A positive TST is particularly useful to indicate
TB infection when there is no known TB
exposure on clinical assessment, i.e. no
positive contact history.
Caution: a positive TST does not distinguish
between TB infection and active disease.
A negative TST does not exclude TB disease.
35
Bacteriological Confirmation
Children usually have paucibacillary pulmonary
disease (low organism numbers), as cavitating
disease is relatively rare.
All attempts must be made to confirm diagnosis
of TB in a child using whatever specimens and
laboratory facilities are available.
36
Chest X-Ray
CXR remains an important tool for diagnosis of PTB in
children who are sputum smear negative or who cannot
produce sputum.
The following abnormalities on CXR are suggestive of TB:
Enlarged hilar lymph nodes and opacification in the
lung tissue
Miliary mottling in lung tissue
Cavitation (common with older children),Pleural or
pericardial effusion
The finding of marked abnormality on CXR in a child with
no signs of respiratory distress (no fast breathing or
chest in-drawing) is supportive of TB
37
Investigations for Common Forms
of Extrapulmonary TB in Children
38
Cont’d
Smear +ve TB:
The criteria are:
Two or more initial sputum smear examinations positive
for acid fast bacilli; or
One sputum smear examination positive for acid fast
bacilli plus CXR abnormalities consistent with active
pulmonary TB, as determined by a clinician; or
One sputum smear examination positive for acid fast
bacilli plus sputum culture positive for M. tuberculosis.
39
Cont’d
Smear -ve TB:
41
Cont’d
If AFB is negative, Dx is based on:
Contact with patient(adult) with pulmonary TB
S/Sx suggestive of TB
X-Ray finding consistent with TB
Positive TST
If 3 are fullfilled, TB is likely Dx
If severe malnutrition or immunosupresion, 2
criteria are enough
42
HIV Testing
HIV counseling and testing is indicated for all
TB patients as part of their routine
management.
43
Mx of Childhood TB
Principles :
Chemotherapy/Anti TB drugs
Nutritional rehabilitation
44
Anti TB Drugs
The main objectives of anti TB treatment are to:
Cure the patient (by rapidly eliminating most of the
bacilli);
Prevent death from active TB or its late effects;
Prevent relapse of TB (by eliminating the dormant bacilli);
Prevent the development of drug resistance (by using a
combination of drugs);
Decrease TB transmission to others.
45
Recommended treatment
regimen
Anti-TB treatment is divided into two phases:
an intensive phase and
a continuation phase.
46
Second line anti TB drugs for
treatment of MDR-Tb in children
Ethionamide or prothionamide
Fluoroquinolones
Ofloxacin
Levofloxacin
Moxifloxacin
Gatifloxacin
Ciprofloxacin
Aminoglycosides
Kanamycin
Amikacin
Capreomycin
Cycloserine or terizidone
paraAminosalicylic acid
47
Steroids in TB
Meningitis
Pericarditis
Adrenal insufficiency
Airway obstruction (LAP, laryngeal TB)
Bilateral pleural effusion with respiratory
problem
Indications for prescribing steroids in renal TB:
Severe bladder symptoms
Tubular structure involvement (eg, ureter, fallopian
tubes, spermatic cord)
48
Prevention of Childhood TB
Case finding and treatment, which interrupts
transmission of infection between close
contacts
Bacille Calmette-Guerin Vaccination
INH prophylaxis
49